Functional characterization of antibodies against heparin-platelet factor 4 complex in heparin-induced thrombocytopenia patients in Asian-Indians: Relevance to inflammatory markers

Blood Coagulation and Fibrinolysis

Volumn 16, Issue 7, 2005, Pages 487-490

  Kannan, Meganathan ^a   Ahmad, Sarfraz ^b,c   Ahmad, Firdos ^a   Kale, Shailaja ^a   Hoppensteadt, Debra A ^b   Fareed, Jawed ^b   Saxena, Renu ^a,d  

^a ALL INDIA INSTITUTE OF MEDICAL SCIENCES   (India)

^b LOYOLA UNIVERSITY CHICAGO   (United States)

^c FLORIDA HOSPITAL CANCER INSTITUTE   (United States)

^d INSTITUTE ROTARY CANCER HOSPITAL   (India)

Author keywords

Asian Indian subjects; Heparin induced thrombocytopenia; Heparin PF4 antibodies; Inflammatory markers; Laboratory tests

Indexed keywords

BIOLOGICAL MARKER; C REACTIVE PROTEIN; CD40 LIGAND; HEPARIN; HEPARIN PLATELET FACTOR 4 ANTIBODY; SEROTONIN;

ADOLESCENT; ADULT; AGED; ANTIBODY DETECTION; ARTICLE; ASIAN; CARDIOVASCULAR SURGERY; CHILD; CLINICAL ARTICLE; CONTROLLED STUDY; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; HEPARIN INDUCED THROMBOCYTOPENIA; HUMAN; INDIAN; INFLAMMATION; MALE; PRIORITY JOURNAL; SEROTONIN RELEASE; THROMBOCYTE AGGREGATION; THROMBOCYTE COUNT;

EID: 29144477113     PISSN: 09575235     EISSN: None     Source Type: Journal    
DOI: 10.1097/01.mbc.0000178829.31902.0a     Document Type: Article

References (21)

1. Warkentin TE, Greinacher A. Heparin-induced thrombocytopenia: recognition, treatment, and prevention. The Seventh ACCP Conference on Antithrombotic and Thrombolytic Therapy. Chest 2004; 126 (suppl 3):311S-337S.
2. Fabris F, Ahmad S, Cella G, Jeske WP, Walenga JM, Fareed J. Pathophysiology of heparin-induced thrombocytopenia: clinical and diagnostic implications - a review. Arch Pathol Lab Med 2000; 124:1657-1666.
3. Amiral J, Marfaing-Koka A, Poncz M, Meyer D. The biological basis of heparin-induced thrombocytopenia. Platelets 1998; 9:77-91.
4. Amiral J. Antigens involved in heparin-induced thrombocytopenia. Semin Hematol 1999; 36 (suppl 1):7-11.
5. Ahmad S, Untch B, Haas S, Hoppensteadt DA, Misselwitz F, Messmore HL, et al. Differential prevalence of anti-heparin-PF4 immunoglobulin subtypes in patients treated with clivarin and heparin: implications in the HIT pathogenesis. Mol Cell Biochem 2004; 258:163-170.
6. Kannan M, Ahmed R, Kale S, Ahmad S, Fareed J, Saxena R. Laboratory diagnosis of heparin-induced thrombocytopenia in Asian Indians as investigated with functional and immunologic methods. Clin Appl Thromb Hemost 2004; 10:51-54.
7. Ahmad S, Walker JM, Drexler A, Reyes E, Palmer GJ III, Moroose R, Francis JL. Bovine heparin generates significantly more functional heparin-PF4 antibodies of the IgG subtype than porcine heparin following cardiac surgery [Abstract]. Blood 2003; 102 (suppl 1):A2982.
8. Elalamy I, Lecrubier C, Horellou MH, Conard J, Samama MM. Heparin-induced thrombocytopenia: laboratory diagnosis and management. Ann Med 2000; 32 (suppl 1):60-67.
9. Risch L, Bertschmann W, Heijnen IA, Huber AR. A differentiated approach to assess the diagnostic usefulness of a rapid particle gel immunoassay for the detection of antibodies against heparin-platelet factor 4 in cardiac surgery patients. Blood Coagul Fibrinolysis 2003; 14:99-106.
10. Sheridan D, Carter C, Kelton JG. A diagnostic test for heparin-induced thrombocytopenia. Blood 1986; 67:27-30.
11. Warkentin TE, Levine MN, Hirsh J, Horsewood P, Roberts RS, Gent M, Kelton JG. Heparin-induced thrombocytopenia in patients treated with low-molecular-weight heparin or unfractionated heparin. N Engl J Med 1995; 332:1330-1335.
12. Blank M, Shoenfeld Y, Tavor S, Praprotnik S, Boffa MC, Weksler B, et al. An anti-platelet factor 4/heparin antibodies from patients with heparin-induced thrombocytopenia provoke direct activation of microvascular endothelial cells. Int Immunol 2002; 14:121-129.
13. Herbert JM, Savi P, Jeske WP, Walenga JM. Effect of SR121566A, a potent GPIIb-IIIa antagonist, on the HIT serum/heparin-induced platelet-mediated activation of human endothelial cells. Thromb Haemost 1998; 80:326-331.
14. Cines DB, Tomaski A, Tannenbaum S. Immune endothelial cell injury in heparin-associated thrombocytopenia. N Engl J Med 1987; 316:581-589.
15. Ahmad S, Amirkhosravi A, Walker JM, Desai H, Amaya M, Siddiqui FA, Francis JL. Functional consequences of cellular interactions with heparin-PF4 antibodies in heparin-induced thrombocytopenia [Abstract]. Blood 2004; 104 (suppl 1):A3498.
16. Pouplard C, Iochmann S, Renard B, Herault O, Colombat P, Amiral J, Gruel Y. Induction of monocyte tissue factor expression by antibodies to heparin-platelet factor 4 complexes developed in heparin-induced thrombocytopenia. Blood 2001; 97:3300-3302.
17. Henn V, Slupsky JR, Grafe M. CD40 ligand on activated platelets triggers an inflammatory reaction of endothelial cells. Nature 1998; 391:591-594.
18. Ahn ER, Lander G, Jy W, Bidot CJ, Jimenez JJ, Horstman LL, Ahn YS. Differences of soluble CD40L in sera and plasma: implications on CD40L assay as a marker of thrombotic risk. Thromb Res 2004; 114:143-148.
19. Weyrich AS, Lindemann S, Zimmermann GA. The evolving role of platelets in inflammation. J Thromb Haemost 2003; 1:1897-1905.
20. Du Clos TW. C-reactive protein and the immune response. Sci Med 2002; 8:108-117.
21. Chilver-Stainer L, Lammle B, Alberio L. Titre of anti-heparin/PF4- antibodies and extent of in vivo activation of the coagulation and fibrinolytic systems. Thromb Haemost 2004; 91:276-282.